FISH probes from CytocellEnquiries: +44 (0)1223 294048probes@cytocell.com
Login
Aquarius® Haematology probes
<< View by disease state

As long ago as the 19th Century, nuclear changes were recognised as being significant in cancer biology. Advances in cytogenetics and molecular cytogenetics in the last century showed that although a number of numerical and structural chromosome changes appeared to be random and non-specific, rearrangements involving individual chromosomes were shown to define specific abnormalities in individual tumour types.

Fluorescence In Situ Hybridisation (FISH) using locus-specific probes which are capable of defining these stereotypic structural rearrangements has now become a routine diagnostic test in the clinical laboratory. The technique has thus been shown to be useful in the management of cancer patients.

Cytocell offers a range of FISH probes specific for a number of haematological malignancies which are available in the Aquarius® liquid format. These probes are directly labelled, ready to use in hybridisation buffer and available in economical 5, and larger 10 test kits. The protocol is rapid and simple and has been developed to allow co-denaturation of the FISH probe and target DNA simultaneously.

The probe mixtures are designed for Fluorescence In Situ Hybridisation of interphase cells and metaphase chromosomes from cultured peripheral blood cells or cultured bone marrow samples.

Also Available

myProbes® custom made FISH probes

myProbes® is a custom FISH probe design and manufacture service, which utilises Cytocell's proprietary BAC clone collection. If a product you require does not appear in the catalogue, do not hesitate to contact Cytocell with your request.

Chromoprobe Multiprobe® Haematology Devices

The Chromoprobe Multiprobe® haematology devices are panels made up of 8 squares, with each one containing a prognostically important probe set for the disease. They are designed to detect multiple rearrangements that occur in ALL; CLL and low grade lymphoma; AML and MDS . These can be used to rapidly determine genotype in leukaemia patients and aid in prognosis and future treatment decisions.

CLL Screening Panel

  • P53 del, ATM del, MYB del, 13q14.3 del, 12 cen
View >>

This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.

Accreditation Name ?? Accreditation Name ?? Accreditation Name ?? Developed &
produced in the UK
Cytocell Ltd 3-4 Technopark Newmarket Road Cambridge CB5 8PB United KingdomTel: +44(0) 1223 294048Fax: +44(0) 1223 294986probes@cytocell.com